Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Hermann

Showing results (1-10 of 100) with videos related to

Pageof 10
Sort By:
Current Rheumatology Reports|January 28, 2009
Cardiovascular risk associated with nonsteroidal anti-inflammatory drugsMatthias Hermann
Journal of Cardiovascular Pharmacology|June 21, 2006
Cyclooxygenase-2 and nitric oxideMatthias Hermann
Current Hypertension Reports|March 28, 2008
Vitamin D and hypertensionMatthias Hermann, Frank Ruschitzka
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 25, 2006
Novel anti-inflammatory drugs in hypertensionMatthias Hermann, Frank Ruschitzka
Annals of Medicine|March 17, 2007
Cardiovascular risk of cyclooxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugsMatthias Hermann, Frank Ruschitzka
Praxis|October 19, 2023
[«Diabetes Drugs» without Diabetes: SGLT-2 Inhibitors]Danaë Parianos, Matthias Hermann
Nature Clinical Practice. Nephrology|August 26, 2006
Are there differences in the renal effects of selective cyclo-oxygenase 2 inhibitors?Matthias Hermann, Thomas F Lüscher
Current Hypertension Reports|January 17, 2009
The hypertension peril: lessons from CETP inhibitorsMatthias Hermann, Frank T Ruschitzka
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|August 6, 2009
Implications of vascular endothelial growth factor for postischemic neurovascular remodelingDirk Matthias Hermann, Anil Zechariah
Praxis|October 14, 2020
[CME: Left Bundle Branch Block and Painful Left Bundle Branch Block Syndrome]Luca Oechslin, Daniel Hofer, Matthias Hermann
Pageof 10

Showing results (1-10 of 100) with videos related to

Sort By:
Pageof 10
Current Rheumatology Reports|January 28, 2009
Cardiovascular risk associated with nonsteroidal anti-inflammatory drugsMatthias Hermann
Journal of Cardiovascular Pharmacology|June 21, 2006
Cyclooxygenase-2 and nitric oxideMatthias Hermann
Current Hypertension Reports|March 28, 2008
Vitamin D and hypertensionMatthias Hermann, Frank Ruschitzka
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 25, 2006
Novel anti-inflammatory drugs in hypertensionMatthias Hermann, Frank Ruschitzka
Annals of Medicine|March 17, 2007
Cardiovascular risk of cyclooxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugsMatthias Hermann, Frank Ruschitzka
Praxis|October 19, 2023
[«Diabetes Drugs» without Diabetes: SGLT-2 Inhibitors]Danaë Parianos, Matthias Hermann
Nature Clinical Practice. Nephrology|August 26, 2006
Are there differences in the renal effects of selective cyclo-oxygenase 2 inhibitors?Matthias Hermann, Thomas F Lüscher
Current Hypertension Reports|January 17, 2009
The hypertension peril: lessons from CETP inhibitorsMatthias Hermann, Frank T Ruschitzka
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|August 6, 2009
Implications of vascular endothelial growth factor for postischemic neurovascular remodelingDirk Matthias Hermann, Anil Zechariah
Praxis|October 14, 2020
[CME: Left Bundle Branch Block and Painful Left Bundle Branch Block Syndrome]Luca Oechslin, Daniel Hofer, Matthias Hermann
Pageof 10